EUVIMEDOpdag EUVIMED
ÜbersichtsarbeitOpen access · CC BY 4.0

Oxidative Stress in Diabetic Retinopathy: A Comprehensive Review of Mechanisms, Biomarkers, and Therapeutic Perspectives

Tatsuya Mimura, Hidetaka Noma iD

Antioxidants · 2025-10-04 · 14 (10) · 1204

DOI: 10.3390/antiox14101204 ↗

At a glance

Übersichtsarbeit in Antioxidants, published online on 2025-10-04. Written by Tatsuya Mimura and 1 co-authors. Institution: Department of Ophthalmology, School of Dental Medicine, Tsurumi University, Yokohama 230-0063, Japan. Cited 42 times so far (Crossref); 55 references. The full text is freely available (open access, CC BY 4.0).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Diabetic retinopathy (DR) is a leading cause of vision loss globally and represents one of the most common microvascular complications of diabetes. In addition to metabolic disturbances associated with hyperglycemia, oxidative stress has emerged as a critical contributor to the onset and progression of DR. Oxidative stress, defined as an imbalance between the production of reactive oxygen species (ROS) and antioxidant defense mechanisms, leads to cellular injury, inflammation, and increased vascular permeability. In the diabetic retina, excessive ROS production promotes endothelial cell apoptosis, breakdown of the blood-retinal barrier (BRB), and induction of angiogenic factors such as vascular endothelial growth factor (VEGF). This review provides a comprehensive overview of the pathophysiology of DR, focusing on the molecular mechanisms of oxidative stress. Relevant studies were identified through a structured search of PubMed, Web of Science, and Scopus (2000–2025) using terms such as ‘diabetic retinopathy’, ‘oxidative stress’, and ‘antioxidants’. We explore current knowledge on oxidative stress-related biomarkers and therapeutic strategies targeting oxidative damage, including antioxidant compounds and mitochondrial protective agents. Recent findings from both experimental and clinical studies are summarized, highlighting the translational potential of oxidative stress modulation in DR management. Finally, future research directions are discussed, including biomarker standardization, personalized medicine approaches, and long-term clinical validation of antioxidant-based therapies. A deeper understanding of oxidative stress may offer valuable insights into novel diagnostic and therapeutic strategies for DR.

Subjects

Author keywords

antioxidant therapyblood-retinal barrier (BRB)diabetic retinopathymitochondrial dysfunctionoxidative stressreactive oxygen species (ROS)

Authors and institutions

  • Department of Ophthalmology, School of Dental Medicine, Tsurumi University, Yokohama 230-0063, Japan.
  • Department of Ophthalmology, Tokyo Medical University Ibaraki Medical Center, Ami-cho 300-0395, Japan.

ORCID profiles: Hidetaka Noma

Cite

APA

Mimura, T., & Noma, H. (2025). Oxidative Stress in Diabetic Retinopathy: A Comprehensive Review of Mechanisms, Biomarkers, and Therapeutic Perspectives. Antioxidants, 14(10), 1204. https://doi.org/10.3390/antiox14101204

Vancouver

Mimura T, Noma H. Oxidative Stress in Diabetic Retinopathy: A Comprehensive Review of Mechanisms, Biomarkers, and Therapeutic Perspectives. Antioxidants. 2025;14(10):1204. doi:10.3390/antiox14101204

BibTeX
@article{Mimura2025,
  author = {Mimura, Tatsuya and Noma, Hidetaka},
  title = {Oxidative Stress in Diabetic Retinopathy: A Comprehensive Review of Mechanisms, Biomarkers, and Therapeutic Perspectives},
  journal = {Antioxidants},
  year = {2025},
  volume = {14},
  number = {10},
  pages = {1204},
  doi = {10.3390/antiox14101204}
}
Start for free →